TwistDx’s mission is to become the world leader in the development and sale of mobile and point-of-use diagnostics.
The company owns a substantial portfolio of intellectual property covering all aspects of the Recombinase Polymerase Amplification (RPA) technology, which it is using to develop a growing range of innovative, market-leading products in the fields of:
› Medical Diagnostics
› Food Testing
› Animal Health
› Environmental Testing
› Scientific Research
TwistDx Inc. was founded in 1999 by molecular biologist and protein biochemist, Dr Niall Armes, together with Dr Derek Stemple and Dr Nagesh Mahanthappa with its headquarters in Cambridge, Massachusetts, USA. TwistDx Limited was formed in 2002, its operational facilities are in Cambridge, UK.